Clinical Trials Browser

Completed × OTHER × 4,17 beta-dihydroxy-4-androstene-3-one × Clear all

NCT02993159 2024-12-18

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Phase 2 Completed

100 enrolled 15 charts

Carcinoma, Intraductal, Noninfiltrating

NCT03063619 2024-02-22

Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast

Phase 2 Completed

194 enrolled 12 charts

Mammographically Dense Breast